PMC:7461420 / 47864-48526
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T241 | 291-295 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T600 | 34-35 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T601 | 52-59 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
T602 | 82-83 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T603 | 125-127 | http://purl.obolibrary.org/obo/CLO_0008307 | denotes | P2 |
T604 | 159-167 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptidic |
T605 | 194-195 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T606 | 276-282 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
T607 | 326-329 | http://purl.obolibrary.org/obo/CLO_0001079 | denotes | 148 |
T608 | 396-398 | http://purl.obolibrary.org/obo/CLO_0008307 | denotes | P2 |
T609 | 456-458 | http://purl.obolibrary.org/obo/CLO_0008922 | denotes | S2 |
T610 | 456-458 | http://purl.obolibrary.org/obo/CLO_0050052 | denotes | S2 |
T611 | 478-480 | http://purl.obolibrary.org/obo/CLO_0008285 | denotes | P1 |
T612 | 511-513 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
T613 | 650-656 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T544 | 18-23 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T545 | 52-59 | Chemical | denotes | peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
T546 | 60-70 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T547 | 125-127 | Chemical | denotes | P2 | http://purl.obolibrary.org/obo/CHEBI_33472 |
T548 | 128-138 | Chemical | denotes | cyclohexyl | http://purl.obolibrary.org/obo/CHEBI_52552 |
T549 | 182-192 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T550 | 396-398 | Chemical | denotes | P2 | http://purl.obolibrary.org/obo/CHEBI_33472 |
T551 | 456-458 | Chemical | denotes | S2 | http://purl.obolibrary.org/obo/CHEBI_29387 |
T552 | 478-480 | Chemical | denotes | P1 | http://purl.obolibrary.org/obo/CHEBI_60949 |
T553 | 481-490 | Chemical | denotes | imidazole | http://purl.obolibrary.org/obo/CHEBI_14434|http://purl.obolibrary.org/obo/CHEBI_16069 |
T555 | 622-627 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1453 | 354-358 | Gene | denotes | Mpro | Gene:8673700 |
1454 | 300-304 | Gene | denotes | Mpro | Gene:8673700 |
1455 | 291-299 | Species | denotes | SARS‐CoV | Tax:694009 |
1456 | 84-105 | Chemical | denotes | decahydroisoquinoline | |
1457 | 396-420 | Chemical | denotes | P2‐decahydroisoquinoline | |
1458 | 481-490 | Chemical | denotes | imidazole | MESH:C029899 |
1459 | 628-632 | Disease | denotes | fits | MESH:D012640 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T431 | 0-193 | Sentence | denotes | The same research group disclosed a novel series of peptide inhibitors containing a decahydroisoquinoline moiety in place of P2‐cyclohexyl of 46 to reduce the peptidic nature of the inhibitors. |
T432 | 194-240 | Sentence | denotes | A few examples (47–51) are shown in Figure 16. |
T433 | 241-325 | Sentence | denotes | Among them, 49 was moderately more active against SARS‐CoV Mpro when compared to 46. |
T434 | 326-522 | Sentence | denotes | 148 The X‐ray structure of Mpro in complex with 49 revealed that the P2‐decahydroisoquinoline moiety was fittingly placed in the S2‐subsite, while the P1‐imidazole moiety occupied the S1‐subsite. |
T435 | 523-662 | Sentence | denotes | With these key residues located appropriately in their respective pockets, the terminal functional group fits tightly into the active site. |